#### ![calendar-Icon](/themes/custom/cosmos/patterns/images/calendar-v2.svg)April 28, 2026

 

 #### Basel, Switzerland

 

 

Novartis announces the company’s financial results for the first quarter of 2026.

 

 

 [    Press release  (312 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q1-2026-media-release-en.pdf) [    Medienmitteilung  (324 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q1-2026-media-release-de.pdf) 

 



 [    Interim financial report  (343 KB)   ](https://prod1.novartis.com/sites/novartis_com/files/q1-2026-interim-financial-report-en.pdf) 

 



---

## Investors

[Watch the webcast](https://edge.media-server.com/mmc/p/652bb6yc/ "(opens in a new window)")  
14:00 CEST | 13:00 BST | 08:00 EDT

[Download the podcast (MP3 26 MB)](https://prod1.novartis.com/sites/novartis_com/files/2026-04/q1-2026-investor-presentation.mp3)



[Download the presentation (PDF 5.1 MB)](/sites/novartis_com/files/q1-2026-investor-presentation.pdf "q1-2026-investor-presentation.pdf")

[Download 2026 epidemiology data (PDF 0.7 MB)](/sites/novartis_com/files/novartis-target-patient-populations-2026.pdf "novartis-target-patient-populations-2026.pdf")

[Novartis Q1 2026 impact and sustainability update (PDF 1.6 MB)](/sites/novartis_com/files/novartis-q1-2026-impact-and-sustainability-update.pdf "novartis-q1-2026-impact-and-sustainability-update.pdf")









 



 [ 

 

###  Novartis Pipeline 

Benefiting from our continued focus on innovation, Novartis has one of the industry’s most competitive pipelines.

 

 

 ](https://www.novartis.com/research-development/novartis-pipeline) [ 

 

###  Executive Committee of Novartis (ECN) biographies 

Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the business operations of Group companies.

 

 

 ](/about/executive-committee) 





 

 [Download the Novartis Pipeline as of December 31, 2025 (PDF 0.1 MB)](https://www.novartis.com/sites/novartis_com/files/novartis-pipeline-2025-annual-report.pdf "Download the Novartis Pipeline as of December 31, 2025 (PDF 0.1 MB)")